Dr. Reddy's Laboratories Ltd

Ladies and gentlemen, good day and welcome to the Dr. Reddy's Q4 FY20 earnings conference call. As a reminder, all participant lines will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing star then zero on your touchtone phone. Please note that this conference is being recorded. I now hand the conference over to Mr. Amit Agarwal. Thank you and over to you sir.

Very good morning and good evening to all of you and thank you for joining us today for the Dr. Reddy's earnings conference call for the quarter and full year ended 31st March 2020. Earlier during the day we have released our results and the same are also posted on our website. This call is being recorded and the playback and transcript shall be made available on our website soon. All the discussions and analysis of this call will be based on the IFRS consolidated financial statements. To discuss the business performance and outlook, we have the leadership team of Dr. Reddy comprising Mr. Jeevi Prasad, our co-chairman and managing director, Mr. Erez Israeli, our CEO, Mr. Swamin Chaturvedi, our CFO, and the Investor Relations Team. Please note that today's call is a copyrighted material of Dr. Reddy and cannot be read or trusted or attributed in press or media outlets without the company's expressed written consent. Before I proceed with the call, I would like to remind everyone that the safe hardware contained in today's press release also pertains to this conference call. Now, I hand over the call to Mr. G. V. Prasad. Over to you, sir.

Thank you, Amit. Good evening, good afternoon, and good morning to all the participants. I do hope that you and your families continue to remain safe and healthy during these unprecedented times. Let me quickly provide you with an update on the current situation and how we as an organization are playing our part within the overall healthcare system in these extraordinary times. Our foremost priority is to ensure the health and safety of our employees, patients, healthcare professionals, customers, suppliers, and community at large. We have enhanced the safety requirements across all our working locations Enforced physical distancing norms, mandated use of protective gear and enabled remote working across all our global office locations. We have accepted the new reality and swiftly implemented an effective business continuity plan across the functions and have been able to ensure that our operations continue right through the pandemic situation without compromising on the health and safety of our employees. From a supply perspective, together with the inventory on hand and the continued manufacturing support, we have been able to address the enhanced product demand across various markets. We launched several new products, overcame logistical barriers, and through effective customer engagement have continued the business. In the branded markets, we've been able to effectively leverage the virtual connect model to support healthcare professionals, patients, and other people. Overall, we are truly inspired to see how colleagues across the company have risen to the occasion and overcome every obstacle in the way to fulfill our mission which is to ensure continuous supply of medicines to patients and doctors under safe conditions. We are also playing our part of being an effective socially responsible corporate citizen and have extended support to the communities through various initiatives such as supporting the healthcare workers, staff, and police and other public servants by providing them with PPE kits, masks, sanitizers, gloves, as well as food assistance to the marginal sections and migrant worker families. With this, I hand over the call to Salman for taking you all through the financial performance of the company.